NEOGEN CORP(NASDAQ:NEOG) stock Fundamental Analysis

Fundamental Rating

Overall NEOG gets a fundamental rating of 4 out of 10. We evaluated NEOG against 191 industry peers in the Health Care Equipment & Supplies industry. NEOG has an average financial health and profitability rating. NEOG has a valuation in line with the averages, but it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year NEOG was profitable.

In the past year NEOG had a positive cash flow from operations.

The reported net income has been mixed in the past 5 years: NEOG reported negative net income in multiple years.

In the past 5 years NEOG always reported a positive cash flow from operatings.

1.2 Ratios

With a Return On Assets value of -12.02%, NEOG perfoms like the industry average, outperforming 59.16% of the companies in the same industry.

Looking at the Return On Equity, with a value of -18.24%, NEOG is in the better half of the industry, outperforming 63.35% of the companies in the same industry.

The Return On Invested Capital of NEOG (0.50%) is better than 67.02% of its industry peers.

NEOG had an Average Return On Invested Capital over the past 3 years of 2.71%. This is below the industry average of 7.68%.

		Industry Rank	Sector Rank
ROA	-12.02%
ROE	-18.24%
ROIC	0.5%

ROA(3y)1.38%

ROA(5y)3.65%

ROE(3y)1.47%

ROE(5y)3.97%

ROIC(3y)2.71%

ROIC(5y)4.4%

1.3 Margins

NEOG has a Operating Margin of 2.72%. This is in the better half of the industry: NEOG outperforms 68.59% of its industry peers.

In the last couple of years the Operating Margin of NEOG has declined.

With a Gross Margin value of 48.79%, NEOG perfoms like the industry average, outperforming 41.36% of the companies in the same industry.

In the last couple of years the Gross Margin of NEOG has grown nicely.

		Industry Rank	Sector Rank
OM	2.72%
PM (TTM)	N/A
GM	48.79%

OM growth 3Y-20.27%

OM growth 5Y-13.36%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y3.02%

GM growth 5Y1.61%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NEOG is destroying value.

NEOG has about the same amout of shares outstanding than it did 1 year ago.

NEOG has more shares outstanding than it did 5 years ago.

The debt/assets ratio for NEOG is higher compared to a year ago.

2.2 Solvency

NEOG has an Altman-Z score of 0.89. This is a bad value and indicates that NEOG is not financially healthy and even has some risk of bankruptcy.

Looking at the Altman-Z score, with a value of 0.89, NEOG is in line with its industry, outperforming 52.36% of the companies in the same industry.

A Debt/Equity ratio of 0.33 indicates that NEOG is not too dependend on debt financing.

The Debt to Equity ratio of NEOG (0.33) is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0.33
Debt/FCF	N/A
Altman-Z	0.89

ROIC/WACC0.05

WACC9.65%

2.3 Liquidity

NEOG has a Current Ratio of 3.91. This indicates that NEOG is financially healthy and has no problem in meeting its short term obligations.

Looking at the Current ratio, with a value of 3.91, NEOG is in the better half of the industry, outperforming 66.49% of the companies in the same industry.

NEOG has a Quick Ratio of 2.45. This indicates that NEOG is financially healthy and has no problem in meeting its short term obligations.

Looking at the Quick ratio, with a value of 2.45, NEOG is in line with its industry, outperforming 59.16% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	3.91
Quick Ratio	2.45

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for NEOG have decreased strongly by -20.83% in the last year.

Measured over the past years, NEOG shows a decrease in Earnings Per Share. The EPS has been decreasing by -5.21% on average per year.

The Revenue has decreased by -2.50% in the past year.

The Revenue has been growing by 17.41% on average over the past years. This is quite good.

EPS 1Y (TTM)-20.83%

EPS 3Y-8.53%

EPS 5Y-5.21%

EPS Q2Q%-16.67%

Revenue 1Y (TTM)-2.5%

Revenue growth 3Y25.42%

Revenue growth 5Y17.41%

Sales Q2Q%-3.42%

3.2 Future

The Earnings Per Share is expected to grow by 6.10% on average over the next years.

Based on estimates for the next years, NEOG will show a small growth in Revenue. The Revenue will grow by 1.81% on average per year.

EPS Next Y-14.23%

EPS Next 2Y-1.33%

EPS Next 3Y3.62%

EPS Next 5Y6.1%

Revenue Next Year-1.36%

Revenue Next 2Y0.98%

Revenue Next 3Y1.9%

Revenue Next 5Y1.81%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 13.68, NEOG is valued correctly.

NEOG's Price/Earnings ratio is rather cheap when compared to the industry. NEOG is cheaper than 90.05% of the companies in the same industry.

The average S&P500 Price/Earnings ratio is at 28.92. NEOG is valued rather cheaply when compared to this.

A Price/Forward Earnings ratio of 12.14 indicates a correct valuation of NEOG.

Compared to the rest of the industry, the Price/Forward Earnings ratio of NEOG indicates a rather cheap valuation: NEOG is cheaper than 91.10% of the companies listed in the same industry.

NEOG's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 21.65.

		Industry Rank	Sector Rank
PE	13.68
Fwd PE	12.14

4.2 Price Multiples

83.25% of the companies in the same industry are more expensive than NEOG, based on the Enterprise Value to EBITDA ratio.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	13.27

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-1.33%

EPS Next 3Y3.62%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for NEOG!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

NEOGEN CORP

NASDAQ:NEOG (4/24/2025, 8:00:02 PM)

After market: 5.2 0 (0%)

5.2

+0.28 (+5.69%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)04-09 2025-04-09/bmo

Earnings (Next)07-28 2025-07-28/amc

Inst Owners121.73%

Inst Owner Change0.16%

Ins Owners0.23%

Ins Owner Change18.27%

Market Cap1.13B

Analysts82

Price Target14.96 (187.69%)

Short Float %10.65%

Short Ratio3.92

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)0.34%

Min EPS beat(2)-10.87%

Max EPS beat(2)11.56%

EPS beat(4)1

Avg EPS beat(4)-8.33%

Min EPS beat(4)-19.26%

Max EPS beat(4)11.56%

EPS beat(8)2

Avg EPS beat(8)50.77%

EPS beat(12)4

Avg EPS beat(12)43.66%

EPS beat(16)4

Avg EPS beat(16)25.09%

Revenue beat(2)0

Avg Revenue beat(2)-1.93%

Min Revenue beat(2)-3.66%

Max Revenue beat(2)-0.19%

Revenue beat(4)1

Avg Revenue beat(4)-0.54%

Min Revenue beat(4)-3.66%

Max Revenue beat(4)2.8%

Revenue beat(8)2

Avg Revenue beat(8)-0.83%

Revenue beat(12)2

Avg Revenue beat(12)-1.27%

Revenue beat(16)4

Avg Revenue beat(16)-0.85%

PT rev (1m)0%

PT rev (3m)-9.28%

EPS NQ rev (1m)-30.77%

EPS NQ rev (3m)-45.45%

EPS NY rev (1m)-11.9%

EPS NY rev (3m)-19.57%

Revenue NQ rev (1m)-6.38%

Revenue NQ rev (3m)-13.01%

Revenue NY rev (1m)-1.03%

Revenue NY rev (3m)-3.67%

Valuation

		Industry Rank	Sector Rank
PE	13.68
Fwd PE	12.14
P/S	1.25
P/FCF	N/A
P/OCF	16.49
P/B	0.42
P/tB	N/A
EV/EBITDA	13.27

EPS(TTM)0.38

EY7.31%

EPS(NY)0.43

Fwd EY8.24%

FCF(TTM)-0.2

FCFYN/A

OCF(TTM)0.32

OCFY6.06%

SpS4.17

BVpS12.26

TBVpS-2.08

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-12.02%
ROE	-18.24%
ROCE	0.63%
ROIC	0.5%
ROICexc	0.52%
ROICexgc	2.96%
OM	2.72%
PM (TTM)	N/A
GM	48.79%
FCFM	N/A

ROA(3y)1.38%

ROA(5y)3.65%

ROE(3y)1.47%

ROE(5y)3.97%

ROIC(3y)2.71%

ROIC(5y)4.4%

ROICexc(3y)3.97%

ROICexc(5y)7.43%

ROICexgc(3y)14.92%

ROICexgc(5y)18.11%

ROCE(3y)3.43%

ROCE(5y)5.58%

ROICexcg growth 3Y-23.14%

ROICexcg growth 5Y-16.2%

ROICexc growth 3Y-51.38%

ROICexc growth 5Y-36.83%

OM growth 3Y-20.27%

OM growth 5Y-13.36%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y3.02%

GM growth 5Y1.61%

F-Score4

Asset Turnover0.22

Health

		Industry Rank	Sector Rank
Debt/Equity	0.33
Debt/FCF	N/A
Debt/EBITDA	6.24
Cap/Depr	95.45%
Cap/Sales	12.44%
Interest Coverage	250
Cash Conversion	47.97%
Profit Quality	N/A
Current Ratio	3.91
Quick Ratio	2.45
Altman-Z	0.89

F-Score4

WACC9.65%

ROIC/WACC0.05

Cap/Depr(3y)91%

Cap/Depr(5y)106.13%

Cap/Sales(3y)8.23%

Cap/Sales(5y)7.23%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-20.83%

EPS 3Y-8.53%

EPS 5Y-5.21%

EPS Q2Q%-16.67%

EPS Next Y-14.23%

EPS Next 2Y-1.33%

EPS Next 3Y3.62%

EPS Next 5Y6.1%

Revenue 1Y (TTM)-2.5%

Revenue growth 3Y25.42%

Revenue growth 5Y17.41%

Sales Q2Q%-3.42%

Revenue Next Year-1.36%

Revenue Next 2Y0.98%

Revenue Next 3Y1.9%

Revenue Next 5Y1.81%

EBIT growth 1Y-66.32%

EBIT growth 3Y-0.01%

EBIT growth 5Y1.73%

EBIT Next Year62.88%

EBIT Next 3Y24.17%

EBIT Next 5Y15.27%

FCF growth 1Y46.24%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y331.64%

OCF growth 3Y-24.24%

OCF growth 5Y-11.19%

NEOGEN CORP (NEOG) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens